| JTS1900007 | 雷莫芦单抗 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-03-28 | Eli Lilly and Company（礼来公司） | Eli Lilly & Company | Certificate Issued | 2019-04-22 | view |
| JTS1900045 | 雷莫芦单抗 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-09-05 | Eli Lilly and Company（礼来公司） | Eli Lilly & Company | Certificate Issued | 2019-09-23 | view |
| JYHB0900828 | 奥氮平双羟萘酸盐长效注射剂 | olanzapine pamoate | Injection | Chemical Drugs | Supplementary Application | 2009-09-16 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2010-06-24 | view |
| JXHL1800183 | Lasmiditan(LY573144) 半琥珀酸盐片 | lasmiditan succinate | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-12-25 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2018-12-24 | view |
| J0300543 | 盐酸度洛西汀胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs(1.1) | Import Drug Application | 2003-12-28 | Eli Lilly and Company | Eli Lilly & Company | Approval Completed-Pending Certificated | 2004-04-13 | view |
| JXSL1600001 | 重组赖脯胰岛素 | | | Biological Products | Import Drug Application | 2016-01-31 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-03-09 | view |
| JXHB2000006 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-08-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2020-08-05 | view |
| JXHL1200368 | 盐酸氟西汀胶囊 | fluoxetine hydrochloride | Capsule | Chemical Drugs | Import Drug Application | 2012-12-07 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-12-03 | view |
| JXHL1900352 | 注射用培美曲塞二钠 | pemetrexed disodium | Lyophilized | Chemical Drugs(5.1) | Import Drug Application | 2019-12-21 | ELI LILLY AND COMPANY | Eli Lilly & Company | In Review | 2019-12-20 | view |
| JXHL1000189 | 盐酸普拉格雷片 | prasugrel hydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2010-06-25 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2011-05-16 | view |
| JYSB1900064 | Ramucirumab | ramucirumab | Injection | Biological Products | Supplementary Application | 2019-03-21 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2019-05-27 | view |
| JXHL0800189 | 盐酸Prasugrel | prasugrel hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2008-06-06 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2009-03-02 | view |
| JXSL1700087 | LY900014注射液 | insulin lispro | Injection | Biological Products | Import Drug Application | 2017-12-08 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-11-08 | view |
| JXHL2100058 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-02-25 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2021-02-24 | view |
| JYHZ1400026 | 注射用培美曲塞二钠 | pemetrexed disodium | Lyophilized | Chemical Drugs | License Renew | 2014-02-07 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2014-11-05 | view |
| JXHL2000011 | 注射用培美曲塞二钠 | pemetrexed disodium | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2020-02-15 | ELI LILLY AND COMPANY | Eli Lilly & Company | In Review | 2020-02-14 | view |
| JYHB1100001 | 注射用盐酸吉西他滨 | Gemcitabine hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2011-01-10 | ELI LILLY AND COMPANY | Eli Lilly & Company | Certificate Issued | 2011-12-19 | view |
| JXHL1900071 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-04-10 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-04-09 | view |
| JXHL0900204 | 盐酸Prasugrel | prasugrel hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2009-07-01 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2010-02-05 | view |
| JXHL1800175 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-12-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2018-12-05 | view |
